Gevaert P, Mullol J, Saenz R, Ko J, et al. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status. Ann Allergy Asthma Immunol 2023 Nov 9:S1081-1206(23)01393.
PMID: 37951571